Cargando…
Analysis of prognostic oncogene filaggrin (FLG) wild-type subtype and its implications for immune checkpoint blockade therapy in bladder urothelial carcinoma
BACKGROUND: Bladder urothelial carcinoma (BLCA) is one of the most common urinary tract malignant tumors. Immune checkpoint blockade (ICB) therapy has significantly progressed the treatment of BLCA. This study aimed to investigate the role of specific genetic mutations that may serve as immune bioma...
Autores principales: | Chen, Liang, Huang, Xiaobo, Xiong, Liulin, Chen, Weinan, An, Lizhe, Wang, Huanrui, Hong, Yang, Wang, Huina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641059/ https://www.ncbi.nlm.nih.gov/pubmed/36386263 http://dx.doi.org/10.21037/tau-22-573 |
Ejemplares similares
-
Massively Parallel Sequencing of the Filaggrin Gene Reveals an Association Between FLG Loss-of-function Mutations and Leprosy
por: SHI, Wenhao, et al.
Publicado: (2020) -
Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
por: Guo, Ya, et al.
Publicado: (2022) -
Mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy and its initial clinical application
por: Hong, Yang, et al.
Publicado: (2022) -
GATA3 regulates FLG and FLG2 expression in human primary keratinocytes
por: Zeitvogel, Jana, et al.
Publicado: (2017) -
Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy
por: Cheng, Wen, et al.
Publicado: (2018)